Midollo osseo versus tessuto adiposo come fonte cellulare per il trattamento infiltrativo dell’osteoartrite di ginocchio: trial clinico randomizzato

Title

Code

MAST-GR

Type

Sperimentale

Start Year

2023

Status

In Corso

Principal Investigator

+39-051-6366776

luca.andriolo@ior.it

Andriolo Luca, MD

Applied and Translational Research center (ATRc)

Operational unit that carry out the study

Applied and Translational Research center (ATRc)

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. MAST-GR

Friday 6 December 2024, 16:18

PG0005141_2023_Nulla osta DG_MAST-GR - Andriolo.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Midollo osseo versus tessuto adiposo come fonte cellulare per il trattamento infiltrativo dell’osteoartrite di ginocchio: trial clinico randomizzato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Midollo osseo versus tessuto adiposo come fonte cellulare per il trattamento infiltrativo dell’osteoartrite di ginocchio: trial clinico randomizzato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in